Rxsight, Inc. 8-K Summary: 2025 Annual Meeting Results
Business Context and Reporting Period
This Form 8-K reports the results of the 2025 Annual Meeting of Stockholders held on June 3, 2025. Rxsight, Inc. (RXST) is a Delaware corporation with principal executive offices in Aliso Viejo, California. As of the record date (April 8, 2025), there were 40,620,239 shares of common stock outstanding.
Key Financial Metrics
This filing is a Current Report regarding corporate governance and does not contain financial statements. The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Voting Results
Approximately 79.2% of outstanding shares (32,181,609 shares) were represented at the meeting. The following matters were voted upon:
- Election of Class I Directors: All three nominees were re-elected to serve until the 2028 annual meeting.
- Ron Kurtz, M.D.: 24,110,940 For; 1,608,846 Against; 66,441 Abstain.
- J. Andy Corley: 19,801,689 For; 5,918,311 Against; 66,227 Abstain.
- Juliet Tammenoms Bakker: 19,758,469 For; 5,961,387 Against; 66,371 Abstain.
- Advisory Vote on Executive Compensation: Approved by stockholders.
- 22,365,356 For; 3,322,193 Against; 98,678 Abstain.
- Ratification of Independent Auditor: Ernst & Young LLP was ratified for the fiscal year ending December 31, 2025.
- 31,946,931 For; 92,057 Against; 142,621 Abstain.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly details the procedural outcomes of the annual meeting.
Key Facts for Investor Verification
- Verify the re-election of the Class I directors, noting the significant "Against" votes for J. Andy Corley and Juliet Tammenoms Bakker (approximately 23% of votes cast against each).
- Confirm the ratification of Ernst & Young LLP as the independent auditor for the 2025 fiscal year.
- Note that 6,395,382 broker non-votes were recorded for the director elections and executive compensation vote, indicating shares held by brokers that did not receive instructions from beneficial owners.
- Review the full proxy statement for details on executive compensation and director biographies referenced in this filing.